Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc.verified

MTNB

Price:

$0.751

Market Cap:

$4.17M

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a prescription-only omega-3 free fatty acid-based composition intended for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that is in Phase II clinical trials for the preventio...[Read more]

Industry

Biotechnology

IPO Date

2014-07-21

Stock Exchange

AMEX

Ticker

MTNB

The ROE as of December 2025 (TTM) for Matinas BioPharma Holdings, Inc. (MTNB) is -249.82%

According to Matinas BioPharma Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -249.82%. This represents a change of 317.86% compared to the average of -59.78% of the last 4 quarters.

Matinas BioPharma Holdings, Inc. (MTNB) Historical ROE (quarterly & annually)

How has MTNB ROE performed in the past?

The mean historical ROE of Matinas BioPharma Holdings, Inc. over the last ten years is -108.30%. The current -249.82% ROE has changed 130.67% with respect to the historical average. Over the past ten years (40 quarters), MTNB's ROE was at its highest in in the December 2022 quarter at -0.09%. The ROE was at its lowest in in the December 2024 quarter at -111.11%.

Quarterly (TTM)
Annual

Average

-108.30%

Median

-96.76%

Minimum

-319.51%

Maximum

-32.32%

Matinas BioPharma Holdings, Inc. (MTNB) ROE by Quarter and Year

Discovering the peaks and valleys of Matinas BioPharma Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 235.56%

Maximum Annual ROE = -32.32%

Minimum Annual Increase = -67.21%

Minimum Annual ROE = -319.51%

Quarterly (TTM)
Annual
YearROEChange
2024-319.51%168.04%
2023-119.20%235.56%
2022-35.52%-11.93%
2021-40.34%24.79%
2020-32.32%-31.46%
2019-47.15%-45.95%
2018-87.25%-39.82%
2017-144.98%36.42%
2016-106.28%-29.36%
2015-150.44%-67.21%

Matinas BioPharma Holdings, Inc. (MTNB) Average ROE

How has MTNB ROE performed in the past?

The current ROE of Matinas BioPharma Holdings, Inc. (MTNB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-158.08%

5-year avg

-109.38%

10-year avg

-108.30%

Matinas BioPharma Holdings, Inc. (MTNB) ROE vs. Peers

How is MTNB’s ROE compared to its peers?

Matinas BioPharma Holdings, Inc.’s ROE is less than Brainstorm Cell Therapeutics Inc. (223.86%), less than NeuroSense Therapeutics Ltd. (2.72%), greater than Impact BioMedical Inc. (-528.69%), greater than Addex Therapeutics Ltd (-66.77%), greater than Adial Pharmaceuticals, Inc. (-197.71%), greater than Cardio Diagnostics Holdings, Inc. (-72.79%), greater than VYNE Therapeutics Inc. (-80.55%), less than HCW Biologics Inc. (507.82%), greater than Pasithea Therapeutics Corp. (-99.53%), greater than Acurx Pharmaceuticals, Inc. (-219.56%),

Build a custom stock screener for Matinas BioPharma Holdings, Inc. (MTNB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Matinas BioPharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Matinas BioPharma Holdings, Inc. (MTNB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Matinas BioPharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Matinas BioPharma Holdings, Inc.'s ROE?

How is the ROE calculated for Matinas BioPharma Holdings, Inc. (MTNB)?

What is the highest ROE for Matinas BioPharma Holdings, Inc. (MTNB)?

What is the 3-year average ROE for Matinas BioPharma Holdings, Inc. (MTNB)?

What is the 5-year average ROE for Matinas BioPharma Holdings, Inc. (MTNB)?

How does the current ROE for Matinas BioPharma Holdings, Inc. (MTNB) compare to its historical average?